Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aysel Pehlivanli

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BMC Nephrology|May 26, 2023
Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional studyAysel Pehlivanli, Sahin Eyupoglu, Bilgen Basgut, et al.
BMC Pharmacology & Toxicology|April 18, 2024
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospitalAysel Pehlivanli, Sayeste Akkan Eren, Sule Sengul, et al.
Journal of Chemotherapy (Florence, Italy)|February 27, 2024
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different dosesAysel Pehlivanli, Tuğba Yanik Yalçin, Fatma İrem Yeşiler, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 15, 2024
An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalationAysel Pehlivanli, Cigdem Ozgun, Firdevs Gonca Sasal-Solmaz, et al.
International Journal of Clinical Pharmacy|March 2, 2022
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resourcesAysel Pehlivanli, Rezzan Eren-Sadioglu, Merve Aktar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BMC Nephrology|May 26, 2023
Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional studyAysel Pehlivanli, Sahin Eyupoglu, Bilgen Basgut, et al.
BMC Pharmacology & Toxicology|April 18, 2024
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospitalAysel Pehlivanli, Sayeste Akkan Eren, Sule Sengul, et al.
Journal of Chemotherapy (Florence, Italy)|February 27, 2024
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different dosesAysel Pehlivanli, Tuğba Yanik Yalçin, Fatma İrem Yeşiler, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 15, 2024
An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalationAysel Pehlivanli, Cigdem Ozgun, Firdevs Gonca Sasal-Solmaz, et al.
International Journal of Clinical Pharmacy|March 2, 2022
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resourcesAysel Pehlivanli, Rezzan Eren-Sadioglu, Merve Aktar, et al.
Pageof 1